0001415889-25-004105.txt : 20250214
0001415889-25-004105.hdr.sgml : 20250214
20250214161102
ACCESSION NUMBER: 0001415889-25-004105
CONFORMED SUBMISSION TYPE: SCHEDULE 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20250214
DATE AS OF CHANGE: 20250214
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Compass Therapeutics, Inc.
CENTRAL INDEX KEY: 0001738021
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-90878
FILM NUMBER: 25628683
BUSINESS ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-500-8099
MAIL ADDRESS:
STREET 1: 80 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Olivia Ventures, Inc.
DATE OF NAME CHANGE: 20180419
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: MPM BioImpact LLC
CENTRAL INDEX KEY: 0001687078
ORGANIZATION NAME:
IRS NUMBER: 364818254
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SCHEDULE 13G
BUSINESS ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6174259200
MAIL ADDRESS:
STREET 1: 399 BOYLSTON STREET, SUITE 1100
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: BioImpact Capital LLC
DATE OF NAME CHANGE: 20210831
FORMER COMPANY:
FORMER CONFORMED NAME: MPM Oncology Impact Management LP
DATE OF NAME CHANGE: 20161007
SCHEDULE 13G
1
primary_doc.xml
SCHEDULE 13G
0001687078
XXXXXXXX
LIVE
Common Stock, par value $0.001 per share
12/31/2024
0001738021 Compass Therapeutics, Inc. 20454B104
80 GUEST STREET
BOSTON
MA
02135
Rule 13d-1(b)
MPM BioImpact LLC
DE
8567896.00
0.00
8567896.00
0.00
8567896.00
6.2
IA
Compass Therapeutics, Inc.
80 GUEST STREET, BOSTON, MA, 02135.
MPM BioImpact LLC 399 Boylston Street, Suite 1100
Boston, MA 02116 Delaware
N
IA
8,567,896 6.2%
8,567,896
0
8,567,896
0
Y
Y
Y
Y
Y
N
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
MPM BioImpact LLC
Christopher Wolf
Chief Financial Officer
02/14/2025